NCT05849012 is a NA clinical trial of Low Sulfur Diet in Crohn's Disease in Remission, sponsored by University of Michigan.

Who is sponsoring NCT05849012?

NCT05849012 is sponsored by University of Michigan.

What drugs are being tested in NCT05849012?

Interventions in NCT05849012: Low Sulfur Diet, Usual Diet.

What condition does NCT05849012 study?

NCT05849012 studies Crohn's Disease in Remission.

Is NCT05849012 still recruiting?

NCT05849012 is currently recruiting now. Last updated 15 January 2026.

Last reviewed 2026-01-15 · How we verify

NCT05849012

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Pilot Study Examining Low Sulfur Diet as Treatment for Persistent Symptoms in Quiescent Crohn's Disease

Recruiting now NA Last updated 15 January 2026

What this trial tests

NA trial testing Low Sulfur Diet in Crohn's Disease in Remission in 20 participants. Currently enrolling.

Timeline

12 December 2023

Primary endpoint
30 December 2026

30 April 2027

Quick facts

Lead sponsor	University of Michigan
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	12 December 2023
Primary completion	30 December 2026
Estimated completion	30 April 2027
Sites	1 location across United States

Drugs / interventions tested

Low Sulfur Diet
Usual Diet

Conditions studied

Crohn's Disease in Remission — all drugs for Crohn's Disease in Remission →

Sponsor

University of Michigan

Who can join

18 and older, any sex, with Crohn's Disease in Remission. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to learn about a low sulfur diet in patients with Crohn's disease. Study participants will be randomized to receive a low sulfur diet or usual diet for 8 weeks. Participants will work with study nutritionists and receive dietary educational materials. Participants will attend 2 in-person visits as well as 6 phone visits during the study. In addition, subjects will undergo testing, including a test to measure rectal sensation, a test to look for small intestinal bacterial overgrowth, and a test to measure leaky gut.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Michigan trials

Trials by the same sponsor.

NCT07536919 — Integrating Care for Hypertension-Diabetes MULTImorbidity in Guatemala Through HEARTS Implementation · NA · not yet recruiting
NCT05509842 — Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD) · NA · not yet recruiting
NCT06311188 — Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness · NA · not yet recruiting
NCT07471646 — Effects of Ramadan Fasting With Exercise on Cardiometabolic Health · NA · not yet recruiting
NCT06671925 — A Community Health Worker-Led Program for Chronic Pain and Loneliness in Older Adults · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05849012 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Michigan
Last refreshed: 15 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05849012.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing